Analysis Modernising vaccine surveillance systems to improve detection of rare or poorly defined adverse events BMJ 2019; 365 doi: https://doi.org/10.1136/bmj.l2268 (Published 31 May 2019) Cite this as: BMJ 2019;365:l2268 Article Related content Metrics Responses Peer review Related articles Analysis Challenges of independent assessment of potential harms of HPV vaccines Published: 24 September 2018; BMJ 362 doi:10.1136/bmj.k3694 Research Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia Published: 04 March 2014; BMJ 348 doi:10.1136/bmj.g1458 Research Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis Published: 26 February 2013; BMJ 346 doi:10.1136/bmj.f794 Letter HPV vaccine: adverse event signals were minimised or ignored Published: 05 July 2019; BMJ 366 doi:10.1136/bmj.l4508 Editorial Covid-19 vaccines: delivering protective immunity Published: 17 December 2020; BMJ 371 doi:10.1136/bmj.m4838 See more When I use a word . . . . Medical counterfactuals BMJ May 20, 2022, 377 o1267; DOI: https://doi.org/10.1136/bmj.o1267 The UK’s U-turn on obesity is a failure of leadership BMJ May 20, 2022, 377 o1285; DOI: https://doi.org/10.1136/bmj.o1285 NICE publishes guidance to increase uptake of routine vaccinations BMJ May 20, 2022, 377 o1260; DOI: https://doi.org/10.1136/bmj.o1260 50 candidates in Royal College of Emergency Medicine exam incorrectly told they had passed BMJ May 20, 2022, 377 o1283; DOI: https://doi.org/10.1136/bmj.o1283 Covid-19: JCVI advises further booster for vulnerable adults and health and care workers BMJ May 20, 2022, 377 o1277; DOI: https://doi.org/10.1136/bmj.o1277 Cited by... Covid-19 vaccines: delivering protective immunityFulltext PDF HPV vaccine: adverse event signals were minimised or ignoredFulltext PDF
